Inventor · disambiguated record
Genet Zemede
Also filed as: ZEMEDE GENET
14 granted patents·12 pending applications·362 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
26 records- 0198US11111272B2α4α7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·10 cites·14 claims
- 0298US10626146B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·15 cites·22 claims
- 0398US9518091B2A4B7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·34 cites·21 claims
- 0497US10301371B2Cyclic monomer and dimer peptides having integrin antagonist activityPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted May 28, 2019·19 cites·14 claims
- 0597US10059744B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·22 cites·31 claims
- 0697US9809623B2α4β7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·26 cites·14 claims
- 0797US9714270B2a4B7 integrin thioether peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·27 cites·22 claims
- 0897US7084245B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted Aug 1, 2006·181 cites·72 claims
- 0988US11840581B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Dec 12, 2023·1 cites·17 claims
- 1086US2024209026A1A4b7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1185US7414105B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2005·Granted Aug 19, 2008·6 cites·13 claims
- 1284US7528104B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2004·Granted May 5, 2009·15 cites·47 claims
- 1381US7855175B2Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2008·Granted Dec 21, 2010·3 cites·12 claims
- 1477US8304391B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2009·Granted Nov 6, 2012·2 cites·29 claims
- 1575US2022162261A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1672US2020239523A1NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1770US8729030B2Peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Granted May 20, 2014·1 cites·22 claims
- 1861US2018148477A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1957US2008108564A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2007·Application pending·0 cites
- 2057US2013244939A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 2157US2013130979A1Peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 2254US2008090760A2Compositions and Methods for Inhibiting Cellular ProliferationHEMBROUGH TODD·Filed 2006·Application pending·0 cites
- 2352US2013012685A1Novel peptides that bind to the erythropoietin receptorAFFYMAX INC·Filed 2012·Application pending·0 cites
- 2450US2011282029A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
- 2549US2009005292A1Novel Peptides that Bind to the Erythropoietin ReceptorAFFYMAX INC·Filed 2005·Application pending·0 cites
- 2641US2012157660A1Novel peptides that bind to the erythropoietin receptorHOLMES CHRISTOPHER P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Genet Zemede files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →